Asymchem reports revenue dip, sharp profit decline in 2024

Asymchem Laboratories (Tianjin) [SZSE: 002821] reported a 25.82% dip in operating revenue to 5.805 billion yuan for 2024, and a more pronounced 58.17% decline in net profit attributable to shareholders at 948.95 million yuan, according to the company's annual report summary, reflecting the impact of a large order fulfilled in 2023 that didn't repeat in 2024, and ongoing investment in new services, along with general financial challenges in the biopharma market. However, if the unique circumstance from the previous year is discounted, Asymchem reports 7.40% increase in revenue overall.